Program 2020
CHAIRS:
Session 1: Thomas Hügle & Marc Suter, University Hospital Lausanne
Session 2: Philippe Ryvlin, University Hospital Lausanne & Matthias Seidel, Spitalzentrum Biel / Centre hospitalier Bienne
Session 3: Thomas Hügle, University Hospital Lausanne & Matthias Seidel, Spitalzentrum Biel / Centre hospitalier Bienne
10:30 – 11:00
Welcome Remarks and Introduction
Matthias Seidel , Thomas Hügle, & Kristian Schneider (CEO Spitalzentrum Biel / Centre hospitalier Bienne), Switzerland
11:00 – 11:30
Neurotrophins and Clinical Medicine
Matthias Seidel, Switzerland
11:30 – 12:00
Chronic Pain – Unmet Needs
Bart Morlion, Belgium
12:00 – 12:30
Pain and Inflammation – a Close Relation
Martin Koltzenburg, United Kingdom
12:30 – 13:00
Break
13:00 – 13:30
The Role of Substance P and CGRP in Chronic Pain
Walter Zieglgänsberger, Germany
13:30 – 14:00
Pathophysiology and Novel Treatment Options in Migraine
Antoinette Maassen van den Brink, The Netherlands
14:00 – 14:30
Basic Science of Nerve Growth Factor in Joint Diseases
Victoria Chapman, United Kingdom
14:30 – 15:00
Break
15:00 – 15:30
Nerve Growth Factor Inhibition as a Treatment for Osteoarthritis and Low Back Pain
Nancy Lane, United States
15:30 – 16:00
Inflammatory and Degenerative Chronic Pain Syndromes – Evidence for Novel Treatment Target Molecules
Serge Perrot, France
16:00
Further Directions of Nerve Growth Factor Inhibition and Safety / Concluding remarks
All